FDX1 and ARAF are Mediators of Persisters' Survival in Acute Myeloid Leukemia.
Presented work from the Bhatt Lab at the Winship Cancer Institute identifying FDX1 and ARAF as key mediators of persister-cell survival in acute myeloid leukemia. The poster traces an RNA-Seq + DepMap pipeline that surfaced these targets as candidates for combination therapy aimed at chemoresistance — the cellular state that allows a small subpopulation of leukemic cells to survive lethal therapy and seed relapse.
Audience included undergraduate & graduate students and research faculty across the UGA & Emory cancer-research community.